Imaging Features of Arrhythmogenic Mitral Valve Prolapse: Clinical Cases and Literature Review
Main Article Content
Abstract
Mitral valve prolapse (MVP) is one of the leading causes of primary mitral regurgitation. In addition to complications arising
from valvular insufficiency, MVP can also progress to arrhythmias, ranging from premature ventricular contractions to potentially lifethreatening
episodes such as non-sustained ventricular tachycardia or malignant ventricular arrhythmias. Recently, the term "arrhythmic
mitral valve prolapse syndrome" has been reported as a potential cause of sudden cardiac death. Consequently, there has been
increasing research interest in this condition, accompanied by updated guidelines from various cardiovascular societies. Arrhythmic
MVP is classified as a distinct subgroup characterized by frequent or complex ventricular arrhythmias without underlying structural
arrhythmogenic substrate, with or without mitral annular disjunction (MAD). Studies have demonstrated that MAD is associated
with an increased risk of arrhythmias and sudden cardiac death in patients with MVP. Advances in cardiac imaging, particularly
cardiac magnetic resonance (CMR), now enable comprehensive evaluation of this condition. Moreover, CMR plays a pivotal role in
arrhythmic risk stratification and in identifying high-risk myocardial fibrosis patterns.
This article presents a series of clinical cases along with a literature review to provide additional information and updated insights
into this condition.
Keywords
arrhythmic mitral valve prolapse, mitral annular disjunction, cardiac magnetic resonance.
Article Details
References
2. Sabbag, A., et al., EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex in collaboration with the ESC Council on valvular heart disease and the European Association of Cardiovascular Imaging endorsed cby the Heart Rhythm Society, by the Asia Pacific Heart Rhythm Society, and by the Latin American Heart Rhythm Society. 2022. 24 (12): p. 1981-2003.
3. Vahanian, A., et al., 2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). 2022. 43 (7): p. 561-632.
4. Essayagh, B., et al., Presentation and outcome of arrhythmic mitral valve prolapse. 2020. 76 (6): p. 637-649.
5. Miller, M.A., et al., Arrhythmic mitral valve prolapse: JACC review topic of the week. 2018. 72 (23 Part A): p. 2904- 2914.
6. Hutchins, G.M., G.W. Moore, and D.K.J.N.E.J.o.M. Skoog, The association of floppy mitral valve with disjunction of the mitral annulus fibrosus. 1986. 314 (9): p. 535-540.
7. Dejgaard, L.A., et al., The mitral annulus disjunction arrhythmic syndrome. 2018. 72 (14): p. 1600-1609.
8. Perazzolo Marra, M., et al., Morphofunctional abnormalities of mitral annulus and arrhythmic mitral valve prolapse. 2016. 9(8): p. e005030.
9. Lee, A.P.-W., et al., Functional implication of mitral annular disjunction in mitral valve prolapse: a quantitative dynamic 3D echocardiographic study. 2017. 10 (12): p. 1424-1433.
10. Konda, T., et al., The analysis of mitral annular disjunction detected by echocardiography and comparison with previously reported pathological data. 2017. 15: p. 176-185.
11. Muthukumar, L., et al., The Pickelhaube sign: novel echocardiographic risk marker for malignant mitral valve prolapse syndrome. 2017. 10 (9): p. 1078-1080.
12. Kitkungvan, D., et al., Myocardial fibrosis in patients with primary mitral regurgitation with and without prolapse. 2018. 72 (8): p. 823-834.
13. Han, Y., et al., Cardiovascular magnetic resonance characterization of mitral valve prolapse. 2008. 1 (3): p. 294-303.
14. Basso, C., et al., Arrhythmic mitral valve prolapse and sudden cardiac death. 2015. 132 (7): p. 556-566.
15. Constant Dit Beaufils, A.-L., et al., Replacement myocardial fibrosis in patients with mitral valve prolapse: relation to mitral regurgitation, ventricular remodeling, and arrhythmia. 2021. 143 (18): p. 1763-1774.
16. Oliveri, F., et al., Arrhythmic mitral valve prolapse: Diagnostic parameters for high-risk patients: A systematic review and meta‐analysis. 2021. 44 (10): p. 1746-1755.
17. Basso, C., et al., Mitral Valve Prolapse, Ventricular Arrhythmias, and Sudden Death. 2019. 140 (11): p. 952-964.
18. Bui, A.H., et al., Diffuse myocardial fibrosis in patients with mitral valve prolapse and ventricular arrhythmia. 2017. 103 (3): p. 204-209